Article 4 – Decree of August 2, 2019 authorizing the use of treatments by patients infected with the Ebola virus or health care personnel exposed to the Ebola virus

The traceability of the drugs mentioned in article 1 is ensured by the pharmaceutical establishment of the National Public Health Agency.
The collection of undesirable effects and their transmission to the National Agency for the Safety of Medicines and Health Products are carried out by the health professional taking care of the patient.
At the request of the Director General of the National Agency for the Safety of Medicines and Health Products, the withdrawal of batches is implemented by the National Public Health Agency.

Share on facebook
Facebook
Share on pinterest
Pinterest
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending